For Drug Developers
Precision Oncology
Headline
Our patient-derived 3D tumor models are essential to optimize treatment pathways for targeted cancers. By providing a platform for validating efficacy and biomarker data, researchers and practitioners can make data-driven decisions faster than ever before. As the disease evolves or progresses, adjustments to drug regimens can be tested and the combined power of our lab validation and technology platform provides predictive treatment recommendations.
